BRPI0310123B8 - polipeptídeos recombinantes úteis para diagnosticar infecção pelo trypanosoma cruzi, vetor codificando os mesmos, kit compreendendo os referidos polipeptídeos, bem como método de detecção da presença de anticorpos anti-trypanosoma cruzi em uma amostra de um indivíduo - Google Patents

polipeptídeos recombinantes úteis para diagnosticar infecção pelo trypanosoma cruzi, vetor codificando os mesmos, kit compreendendo os referidos polipeptídeos, bem como método de detecção da presença de anticorpos anti-trypanosoma cruzi em uma amostra de um indivíduo

Info

Publication number
BRPI0310123B8
BRPI0310123B8 BRPI0310123A BR0310123A BRPI0310123B8 BR PI0310123 B8 BRPI0310123 B8 BR PI0310123B8 BR PI0310123 A BRPI0310123 A BR PI0310123A BR 0310123 A BR0310123 A BR 0310123A BR PI0310123 B8 BRPI0310123 B8 BR PI0310123B8
Authority
BR
Brazil
Prior art keywords
trypanosoma cruzi
polypeptides
diagnosing
kit
sample
Prior art date
Application number
BRPI0310123A
Other languages
English (en)
Other versions
BRPI0310123B1 (pt
Inventor
Otsu Keiko
V Kirchhoff Louis
Original Assignee
Otsu Keiko
V Kirchhoff Louis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsu Keiko, V Kirchhoff Louis filed Critical Otsu Keiko
Publication of BRPI0310123B1 publication Critical patent/BRPI0310123B1/pt
Publication of BRPI0310123B8 publication Critical patent/BRPI0310123B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

polipeptídeos recombinantes para diagnosticar a infecção pelo trypanosoma cruzi. a presente invenção refere-se a polipeptídeos recombinantes que são úteis para diagnosticar a tripanossomíase americana, ou a doença de chagas, uma doença causada pelo agente infeccioso trypanosoma cruzi. preferivelmente, as seqüências de dna que codificam as proteínas recombinantes são inseridas em vetores plasmídeos a serem expresos se em um organismo.
BRPI0310123A 2002-12-04 2003-12-04 polipeptídeos recombinantes úteis para diagnosticar infecção pelo trypanosoma cruzi, vetor codificando os mesmos, kit compreendendo os referidos polipeptídeos, bem como método de detecção da presença de anticorpos anti-trypanosoma cruzi em uma amostra de um indivíduo BRPI0310123B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43065402P 2002-12-04 2002-12-04
US60/430,654 2002-12-04
PCT/US2003/038458 WO2004050852A2 (en) 2002-12-04 2003-12-04 Recombinant polypeptides for diagnosing infection with trypanosoma cruzi

Publications (2)

Publication Number Publication Date
BRPI0310123B1 BRPI0310123B1 (pt) 2020-03-24
BRPI0310123B8 true BRPI0310123B8 (pt) 2021-05-25

Family

ID=32469505

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0310123A BRPI0310123B8 (pt) 2002-12-04 2003-12-04 polipeptídeos recombinantes úteis para diagnosticar infecção pelo trypanosoma cruzi, vetor codificando os mesmos, kit compreendendo os referidos polipeptídeos, bem como método de detecção da presença de anticorpos anti-trypanosoma cruzi em uma amostra de um indivíduo
BR0317010-1A BR0317010A (pt) 2002-12-04 2003-12-04 Polipeptìdeos recombinantes para diagnosticar a infecção pelo trypanosoma cruzi

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR0317010-1A BR0317010A (pt) 2002-12-04 2003-12-04 Polipeptìdeos recombinantes para diagnosticar a infecção pelo trypanosoma cruzi

Country Status (7)

Country Link
US (1) US7491515B2 (pt)
AU (1) AU2003297635A1 (pt)
BR (2) BRPI0310123B8 (pt)
CA (2) CA2951595C (pt)
EC (1) ECSP055904A (pt)
MX (1) MXPA05005959A (pt)
WO (1) WO2004050852A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7695925B2 (en) * 2005-11-03 2010-04-13 Inbios International, Inc. Compositions and methods for the detection of Trypanosoma cruzi infection
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
US20080107692A1 (en) * 2006-11-02 2008-05-08 Infectious Disease Research Institute Compositions and methods for the detection of trypanosoma cruzi infection
WO2009086398A2 (en) * 2007-12-27 2009-07-09 Abbott Laboratories Anti-t. cruzi antibodies and methods of use
CN103290030A (zh) * 2012-02-23 2013-09-11 上海交通大学 一种结核分枝杆菌标志物HtdY的重组蛋白及其制备方法和临床应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876734A (en) * 1994-03-24 1999-03-02 Kirchhoff; Louis V. Polypeptides for diagnosing infection with Trypanosoma cruzi
AUPN712795A0 (en) * 1995-12-13 1996-01-11 University Of Melbourne, The Recombinant vaccines

Also Published As

Publication number Publication date
WO2004050852A3 (en) 2005-09-15
CA2508221C (en) 2017-01-03
US20040132077A1 (en) 2004-07-08
MXPA05005959A (es) 2005-11-04
WO2004050852A2 (en) 2004-06-17
CA2508221A1 (en) 2004-06-17
US7491515B2 (en) 2009-02-17
ECSP055904A (es) 2006-09-18
CA2951595A1 (en) 2004-06-17
BR0317010A (pt) 2005-10-25
CA2951595C (en) 2019-11-05
BRPI0310123B1 (pt) 2020-03-24
AU2003297635A8 (en) 2004-06-23
AU2003297635A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
AR038568A1 (es) Anticuerpos anti-a beta y su uso
EA200970263A1 (ru) Полностью человеческая высокопродуктивная система получения усовершенствованных антител и белков
WO2002092836A3 (en) Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof
BRPI0713000A8 (pt) Proteína de ligação multiespecífica de cadeia simples, composição farmacêutica e uso da referida proteína de ligação multiespecífica de cadeia simples
PT1219711E (pt) Vacina de lawsonia intracellularis
ATE512228T1 (de) Induzierbare expressionssysteme
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
BRPI0310123B8 (pt) polipeptídeos recombinantes úteis para diagnosticar infecção pelo trypanosoma cruzi, vetor codificando os mesmos, kit compreendendo os referidos polipeptídeos, bem como método de detecção da presença de anticorpos anti-trypanosoma cruzi em uma amostra de um indivíduo
BRPI0406265B8 (pt) método para análise por eletroforese capilar, método para pesquisa e tipagem de proteínas monoclonais, método de preparação de anticorpos modificados sobrecarregados negativamente e kit para detecção e tipagem de proteínas monoclonais
DE60025704D1 (de) Das goodpasture-antigen bindende protein
DE602004024423D1 (de) Impfstoff mit lawsonia intracellularis-untereinheit
EP1546357A4 (en) IMMUNOGENOUS POLYPEPTIDES FROM MYCOPLASMA HYOPNEUMONIA
UY28652A1 (es) Polipeptidos recombinantes para diagnosticar la infeccion con el trypanosoma cruzi
BR9808251A (pt) Proteìna protetora ou fragmento antigênico da mesma, processo que usa um modelo de desafio ou animal ex vivo, sequência de nucleotìdeos isolada ou sua sequência complementar, célula hospedeira ou sistema de expressão ou vetor, proteìna recombinante, vacina, uso de uma proteìna ou fragmento da mesma, processo para testar uma vacina, anticorpo, teste diagnóstico, e, uso de uma vacina.
DK1226236T3 (da) Polypeptider, der har glucanotransferase-aktivitet, og nucleinsyrer, som koder disse
DE60229966D1 (de) Diabetesmodell
Luvira High-throughput proteomic analysis of the dengue virus secretome and the identification of plasma biomarkers of disease severity
AU2018273799A1 (en) Novel murine parvovirus and uses therefor
PL404498A1 (pl) Test diagnostyczny zakażeń Streptococcus agalactiae
WO2006020824A3 (en) Diagnosis and treatment of kawasaki disease and coronavirus infection
DE502006005985D1 (de) Testsystem zum nachweis von salmonellen
EA200702009A1 (ru) Усовершенствованный способ экспрессирующего клонирования в клетке-хозяине
ATE545654T1 (de) Hyphenspezifische zellwandproteine von candida
Puglisi et al. Identificazione di prodotti ittici mediante dna barcoding Fish identification by dna barcoding
MY173322A (en) Serum infection markers for diagnosis of toxoplasmosis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. ANUIDADE(S).

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2125 DE 27/09/2011.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B65X Notification of requirement for priority examination of patent application
B65Z Priority examination of the patent application refused (request does not comply with dec. 132/06 of 20061117)

Free format text: NEGADO O EXAME PRIORITARIO DO PEDIDO DE PATENTE UMA VEZ QUE NAO FOI ATENDIDO O DISPOSTO NO ART. 6O, I DA RESOLUCAO 068/13.

B150 Others concerning applications: publication cancelled [chapter 15.30 patent gazette]

Free format text: REFERENTE AO DESPACHO 15.24.3 PUBLICADO NA RPI NO 2315 DE 19/05/2015.

B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/12/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2804 DE 01-10-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.